- Palladium-103 brachytherapy for prostate carcinomaJ C Blasko
Seattle Prostate Institute, Seattle, WA 98104, USA
Int J Radiat Oncol Biol Phys 46:839-50. 2000..A report of biochemical outcomes for patients treated with palladium-103 (Pd-103) brachytherapy over a fixed time interval...
- 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapyP D Grimm
Seattle Prostate Institute, Swedish Medical Center, Seattle, WA 98104, USA
Int J Radiat Oncol Biol Phys 51:31-40. 2001..To report 10-year biochemical (prostate-specific antigen [PSA]) outcomes for patients treated with 125I brachytherapy as monotherapy for early-stage prostate cancer...